These results obtained with a homogenous patient group with all patients suffering from advanced high-grade serous ovarian cancer support previous results suggesting elevated KLK5 mRNA levels as an unfavorable marker in ovarian cancer. This evidence concerns the gene KLK5 and ovarian serous adenocarcinoma.